Homestead Advisers Corp Stryker Corp Transaction History

Homestead Advisers Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$246.13 - $285.47 $18,952 - $21,981	77 Added 14.08%	624 $178,000
Q4 2022 Feb 03, 2023	BUY	$205.51 - $253.93 $3,904 - $4,824	19 Added 3.6%	547 $133,000
Q3 2022 Nov 07, 2022	BUY	$189.27 - $231.83 $20,630 - $25,269	109 Added 26.01%	528 $107,000
Q2 2022 Aug 01, 2022	BUY	$194.09 - $276.37 $23,484 - $33,440	121 Added 40.6%	419 $83,000
Q1 2022 May 12, 2022	BUY	$245.33 - $277.77 $9,813 - $11,110	40 Added 15.5%	298 $80,000
Q4 2021 Feb 07, 2022	BUY	$236.63 - $276.44 $14,671 - $17,139	62 Added 31.63%	258 $69,000
Q3 2021 Nov 05, 2021	BUY	$248.9 - $280.09 $16,427 - $18,485	66 Added 50.77%	196 $52,000
Q2 2021 Aug 02, 2021	BUY	$242.95 - $267.0 $31,583 - $34,710	130 New	130 $34,000

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $148B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

Stay updated on Homestead Advisers Corp with notifications on news.